Positron Emission Tomography Quantification of Serotonin-1A Receptor Binding in Medication-Free Bipolar Depression

BACKGROUND Little is known about the serotonin-1A receptor (5-HT1A) in bipolar depression despite altered 5-HT1A binding in major depressive disorder. Utilizing positron emission tomography (PET) and the radioligand N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide ([Carbonyl-C-11]WAY-100635), 5-HT1A binding was compared between depressed bipolar disorder (BD) and controls. METHODS Brain 5-HT1A binding potential (BP(F) = B(max)/K(D), where B(max) = total available receptors, and 1/K(D) = ligand affinity) was measured in 32 currently depressed, medication-free BD subjects and 47 controls. Participants were genotyped for the 5-HT1A promoter polymorphism C(-1019)G. RESULTS The bipolar depressed group demonstrated higher 5-HT1A BP(F) across all regions of interest (ROIs; p = .022). Post hoc analyses indicated that male BD patients had higher 5-HT1A BP(F) than male controls (p = .025), with higher 5-HT1A BP(F) found in every region (by 102% in raphe nuclei and 29% to 50% in the forebrain ROIs); whereas, female subgroups did not differ in 5-HT1A BP(F) (p = .32). Serotonin-1A BP(F) did not correlate with depression severity. The GG genotype was overrepresented at trend level in the BD group (p = .057). Number of G-allele copies was associated with higher 5-HT1A BP(F) in raphe (p = .0050), amygdala (p = .022), and hippocampus (p = .041). CONCLUSIONS Higher 5-HT1A BP(F) in bipolar depressed males suggests higher raphe autoreceptor binding, potentially causing less serotonin release and compensatory upregulation of forebrain postsynaptic 5-HT1A receptors. The raphe effect may be partly genetic. No difference in 5-HT1A BP(F) between BD and control females may reflect greater effect of prior antidepressant exposure in BD females.

[1]  R Todd Ogden,et al.  Higher 5-HT1A Receptor Binding Potential During a Major Depressive Episode Predicts Poor Treatment Response: Preliminary Data from a Naturalistic Study , 2006, Neuropsychopharmacology.

[2]  R Todd Ogden,et al.  Estimation in regression models with externally estimated parameters. , 2005, Biostatistics.

[3]  Christer Halldin,et al.  Sex differences in the serotonin 1A receptor and serotonin transporter binding in the human brain measured by PET , 2008, NeuroImage.

[4]  Frederick K. Goodwin,et al.  Aggression in humans correlates with cerebrospinal fluid amine metabolites , 1979, Psychiatry Research.

[5]  Gustavo Turecki,et al.  Impaired Repression at a 5-Hydroxytryptamine 1A Receptor Gene Polymorphism Associated with Major Depression and Suicide , 2003, The Journal of Neuroscience.

[6]  John A. Rice,et al.  The long-term natural history of the weekly symptomatic status of bipolar I disorder. , 2002, Archives of general psychiatry.

[7]  A. Beck,et al.  An inventory for measuring depression. , 1961, Archives of general psychiatry.

[8]  P. Albert,et al.  Transcriptional regulation at a HTR1A polymorphism associated with mental illness , 2008, Neuropharmacology.

[9]  F. Goodwin,et al.  Manic-Depressive Illness. Bipolar Disorders and Recurrent Depression. Oxford (Oxford University Press) 2007. , 2007 .

[10]  Sati Mazumdar,et al.  Serotonin 1A Receptor Binding and Treatment Response in Late-Life Depression , 2004, Neuropsychopharmacology.

[11]  R. P. Maguire,et al.  Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[12]  H. Anisman,et al.  Serotonin receptor subtype and p11 mRNA expression in stress-relevant brain regions of suicide and control subjects. , 2008, Journal of psychiatry & neuroscience : JPN.

[13]  P A Sargent,et al.  Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment. , 2000, Archives of general psychiatry.

[14]  L. Doncarlos,et al.  Estrogen desensitizes 5-HT1A receptors and reduces levels of Gz, Gi1 and Gi3 proteins in the hypothalamus , 2000, Neuropharmacology.

[15]  L. Judd,et al.  Depressive episodes and symptoms dominate the longitudinal course of bipolar disorder , 2003, Current psychiatry reports.

[16]  K. Lesch,et al.  Complex effects of age and gender on hypothermic, adrenocorticotrophic hormone and cortisol responses to ipsapirone challenge in normal subjects , 1995, Psychopharmacology.

[17]  D. Kupfer,et al.  Serotonin-1A receptor imaging in recurrent depression: replication and literature review. , 2007, Nuclear medicine and biology.

[18]  Juha Markkula,et al.  Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635. , 2008, The international journal of neuropsychopharmacology.

[19]  S. A. Barker,et al.  Estrogen treatment increases the levels of regulator of G protein signaling-Z1 in the hypothalamic paraventricular nucleus: possible role in desensitization of 5-hydroxytryptamine1A receptors , 2004, Neuroscience.

[20]  Ramin V. Parsey,et al.  Altered Serotonin 1A Binding in Major Depression: A [carbonyl-C-11]WAY100635 Positron Emission Tomography Study , 2006, Biological Psychiatry.

[21]  Christer Halldin,et al.  A PET study of 5-HT1A receptors at different phases of the menstrual cycle in women with premenstrual dysphoria , 2006, Psychiatry Research: Neuroimaging.

[22]  M. Hamilton A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.

[23]  J. Ashburner,et al.  Nonlinear spatial normalization using basis functions , 1999, Human brain mapping.

[24]  D. Comings,et al.  A common C-1018G polymorphism in the human 5-HT1A receptor gene. , 1999, Psychiatric genetics.

[25]  L. Naudon,et al.  A chronic treatment with fluoxetine decreases 5-HT1A receptors labeling in mice selected as a genetic model of helplessness , 2002, Brain Research.

[26]  M Slifstein,et al.  Validation and Reproducibility of Measurement of 5-HT1A Receptor Parameters with [carbonyl-11C]WAY-100635 in Humans: Comparison of Arterial and Reference Tissue Input Functions , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[27]  F. Turkheimer,et al.  5-Hydroxytryptamine1A receptor occupancy by novel full antagonist 2-[4-[4-(7-chloro-2,3-dihydro-1,4-benzdioxyn-5-yl)-1-piperazinyl]butyl]-1,2-benzisothiazol-3-(2H)-one-1,1-dioxide: a[11C][O-methyl-3H]-N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide trihydrochlori , 2002, The Journal of pharmacology and experimental therapeutics.

[28]  V. Arango,et al.  Human 5-HT1A receptor C(-1019)G polymorphism and psychopathology. , 2004, The international journal of neuropsychopharmacology.

[29]  C. Montigny,et al.  Role of Somatodendritic 5‐HT Autoreceptors in Modulating 5‐HT Neurotransmission a , 1998, Annals of the New York Academy of Sciences.

[30]  Flügge,et al.  5HT1A‐Receptor Binding in the Brain of Cyclic and Ovariectomized Female Rats , 1999, Journal of neuroendocrinology.

[31]  Victoria Arango,et al.  Regional Heterogeneity of 5-HT1A Receptors in Human Cerebellum as Assessed by Positron Emission Tomography , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[32]  S. Woods,et al.  The economic burden of bipolar disease. , 2000, The Journal of clinical psychiatry.

[33]  M. Thase Bipolar depression: Diagnostic and treatment considerations , 2006, Development and Psychopathology.

[34]  D. Kupfer,et al.  Pet imaging of serotonin 1A receptor binding in depression , 1999, Biological Psychiatry.

[35]  Stephen M Smith,et al.  Fast robust automated brain extraction , 2002, Human brain mapping.

[36]  J. John Mann,et al.  Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims , 1995, Brain Research.

[37]  J. Fleiss,et al.  The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. , 1976, Archives of general psychiatry.

[38]  Stephen M. Smith,et al.  A global optimisation method for robust affine registration of brain images , 2001, Medical Image Anal..

[39]  J. Oehler,et al.  The influence of sex and social isolation housing on pre- and postsynaptic 5-HT1A receptors , 2006, Brain Research.

[40]  R. Kessler,et al.  Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. , 2007, Archives of general psychiatry.

[41]  L. D. van de Kar,et al.  Daily injections of fluoxetine induce dose-dependent desensitization of hypothalamic 5-HT1A receptors: reductions in neuroendocrine responses to 8-OH-DPAT and in levels of Gz and Gi proteins. , 1999, The Journal of pharmacology and experimental therapeutics.

[42]  R. C. Young,et al.  A Rating Scale for Mania: Reliability, Validity and Sensitivity , 1978, British Journal of Psychiatry.

[43]  M. Thase,et al.  Prospective predictors of suicide and suicide attempts in 1,556 patients with bipolar disorders followed for up to 2 years. , 2006, Bipolar disorders.

[44]  M. Boldrini,et al.  Serotonin-1A autoreceptor binding in the dorsal raphe nucleus of depressed suicides. , 2008, Journal of psychiatric research.

[45]  Victoria Arango,et al.  Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A receptor binding potential measured by PET using [C-11]WAY-100635 , 2002, Brain Research.

[46]  L. Uphouse,et al.  Gender and estrous cycle effects of the 5-HT1A agonist, 8-OH-DPAT, on hypothalamic serotonin , 1995, Pharmacology Biochemistry and Behavior.

[47]  G. Rajkowska,et al.  Increase in Serotonin-1A Autoreceptors in the Midbrain of Suicide Victims with Major Depression—Postmortem Evidence for Decreased Serotonin Activity , 1998, The Journal of Neuroscience.

[48]  A. Lammertsma,et al.  Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.